Log in to save to my catalogue

Impact of SARS‐CoV‐2 infection and COVID‐19 pandemic on the morbidity and mortality of amyotrophic l...

Impact of SARS‐CoV‐2 infection and COVID‐19 pandemic on the morbidity and mortality of amyotrophic l...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11554849

Impact of SARS‐CoV‐2 infection and COVID‐19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain

About this item

Full title

Impact of SARS‐CoV‐2 infection and COVID‐19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain

Publisher

England: John Wiley & Sons, Inc

Journal title

European journal of neurology, 2024-12, Vol.31 (12), p.e16465-n/a

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background and purpose
The purpose was to describe the risk of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, hospitalization for coronavirus disease 2019 (COVID‐19) and related death and to assess the impact of the pandemic in the survival of amyotrophic lateral sclerosis (ALS) patients.
Methods
The risk of SARS‐C...

Alternative Titles

Full title

Impact of SARS‐CoV‐2 infection and COVID‐19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11554849

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11554849

Other Identifiers

ISSN

1351-5101,1468-1331

E-ISSN

1468-1331

DOI

10.1111/ene.16465

How to access this item